by Thomas Carter

History | The Trial | Now

Astron Clinica, which presented at the May '99 GEIF presentation day as Optiscan Limited, unveiled its skin cancer diagnosis product at the British Melanoma Group conference in January. Helped by investors from GEIF, the company raised over £300k to complete the development of the SIAscope. Astron Clinica is now raising second stage funding to finance its launch across three continents. The plan is to float the company within three to five years.

The SIAscope uses SIA - or Spectrophotometric Intracutaneous Analysis - which was invented at the University of Birmingham. The technique measures the way the skin interacts with light and uses this information to build up an accurate map of different types of cells. This enables doctors to see nests of suspicious cells before they start to spread around the body.

next>>